VSV-ZEBOV Geneva Vaccine Trial
NCT02287480
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
115
Enrollment
OTHER
Sponsor class
Conditions
Ebolavirus Disease
Interventions
BIOLOGICAL:
VSV-ZEBOV
Sponsor
University Hospital, Geneva
Collaborators
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]